| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide new uses of safinamide, safinamide derivatives and MAO-B inhibitors in new types of treatment for Parkinson's disease. <P>SOLUTION: The method for treating Parkinson's disease includes the administration of safinamide, a safinamide derivative, or an MAO-B inhibitor, in combination with other Parkinson's disease agents or treatments, such as levodopa/PDI or dopamine agonists. <P>COPYRIGHT: (C)2013,JPO&INPIT |
